CIK 0001671858 · Non-accelerated filer<br>Smaller reporting company
ARS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SPRY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811489190
- Phone
- 858-771-9307
- Business address
- 11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Silverback Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-19 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −12,344 | $14.03 | $173K | 1,285,103 |
| 2025-07-01 | Karas Eric Chief Commercial Officer | Option exercise 10b5-1 | +15,000 | $1.50 | $23K | 25,315 |
| 2025-07-01 | Karas Eric Chief Commercial Officer | Sale 10b5-1 | −15,000 | $16.99 | $255K | 10,315 |
| 2025-07-01 | Karas Eric Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,000 | 544,588 | ||
| 2025-06-27 | Flynn James E 10% owner | Sale | −370,075 | $18.46 | $6.8M | 4,887,254 |
| 2025-06-27 | Flynn James E 10% owner | Sale | −370,074 | $18.46 | $6.8M | 4,887,254 |
| 2025-06-25 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2025-06-25 | Kelly Michael Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-06-25 | Thompson Peter A. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-06-25 | Shah Pratik Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-06-25 | Islam Saqib Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-06-25 | SAUNDERS BRENT L Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-06-25 | SCHNEIDER PHILLIP M Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-06-25 | Shawver Laura Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-06-25 | Dadoo Rajeev Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-06-18 | Karas Eric Chief Commercial Officer | Option exercise 10b5-1 | +15,000 | $1.50 | $23K | 22,696 |
| 2025-06-18 | Karas Eric Chief Commercial Officer | Sale 10b5-1 | −15,000 | $16.00 | $240K | 7,696 |
| 2025-06-18 | Karas Eric Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,000 | 559,588 | ||
| 2025-05-20 | Fitzpatrick Alexander A Chief Legal Officer | Option exercise | +100,000 | $5.58 | $558K | 192,582 |
| 2025-05-20 | Fitzpatrick Alexander A Chief Legal Officer | Sale | −102,969 | $14.10 | $1.5M | 89,613 |
Page 3 of 14 · 267 trades